Animal Vaccine Market

The latest report published by IMARC Group, titled “Animal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on animal vaccine market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global animal vaccine market size reached US$ 13.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.24% during 2024-2032.

Animal vaccines are critical tools in safeguarding the health and welfare of domestic and wild animals. These vaccines stimulate an immune response, protecting animals from various infectious diseases. In agriculture, they play a pivotal role in maintaining the health of livestock, enhancing food security, and supporting livelihoods. In the conservation of wildlife, vaccines contribute to the preservation of endangered species threatened by diseases. Moreover, they can have indirect benefits, reducing the risk of zoonotic diseases spilling over from animals to humans. They are indispensable for maintaining animal health, preventing disease outbreaks, and supporting agriculture and biodiversity conservation efforts.

Request to Get the Sample Report: https://www.imarcgroup.com/animal-vaccine-market/requestsample

Market Trends:

The global market is majorly driven by the increasing demand for meat and dairy products. This rising demand has led to the expansion of livestock production. This heightened livestock density elevates the risk of disease outbreaks, necessitating robust vaccination programs to ensure animal health and productivity. Furthermore, the growing prevalence of zoonotic diseases, where diseases can be transmitted between animals and humans, has raised awareness of the importance of animal vaccination in preventing potential pandemics. This recognition has spurred investments in animal vaccines to protect animal and human health. Moreover, the stringent government regulations and animal health and food safety standards are pushing producers to implement vaccination strategies, boosting market growth. Vaccination is seen as a cost-effective way to comply with these regulations while ensuring the quality of animal products. Additionally, the rapid advancements in biotechnology and vaccine development techniques have led to more effective and safer vaccines. These innovations make vaccines more attractive to producers, further contributing to market expansion.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/animal-vaccine-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• H. Boehringer Sohn AG & Co. KG

• Ceva Sante Animale

• Elanco Animal Health Incorporated (Eli Lilly and Company)

• Hester Biosciences Limited

• Hipra S.A.

• Hygieia Biological Laboratories

• Merck & Co. Inc.

• Phibro Animal Health Corporation

• Vaxxinova GmbH (EW Group)

• Virbae

• Zoetis Services LLC

Animal Vaccine Market Segmentation:

Our report has categorized the market based on region, product, animal type, route of administration.

Breakup by Product:

• Attenuated vaccines

• Inactivated vaccines

• Subunit vaccines

• Toxoid vaccines

• Conjugate vaccines

• Recombinant vaccines

• DNA vaccines Type

Breakup by Animal Type:

• Companion animal  

  • Dogs

  • Cats

• Livestock animal  

  • Cattle

  • Pigs

  • Poultry

  • Sheep

  • Others

• Aquaculture

Breakup by Route of Administration:

• Subcutaneous

• Intramuscular

• Intranasal

• Others

Breakup by Region:

• North America (United States, Canada)

• Europe (Germany, France, United Kingdom, Italy, Spain, Others)

• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

• Market Performance (2018-2023)

• Market Outlook (2024-2032)

• Porter’s Five Forces Analysis

• Market Drivers and Success Factors

• SWOT Analysis

• Value Chain

• Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163